Insider · CIK 0001236927

FRIEDMAN PAUL A

Reports to the SEC for 9 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001236927

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,094 sh	$513.11	−$561K	209,110
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−575 sh	$528.18	−$304K	191,021
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−840 sh	$521.98	−$438K	198,823
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−280 sh	$530.69	−$149K	189,884
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,345 sh	$514.68	−$692K	207,765
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−80 sh	$532.50	−$42.6K	189,804
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,363 sh	$518.68	−$707K	201,190
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−80 sh	$537.85	−$43K	188,284
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−487 sh	$536.88	−$261K	188,364
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−846 sh	$519.88	−$440K	200,344
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−970 sh	$523.00	−$507K	197,853
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,480 sh	$511.98	−$758K	210,204
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−166 sh	$529.76	−$87.9K	190,164
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−148 sh	$535.29	−$79.2K	189,324
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,560 sh	$526.97	−$822K	191,596
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−691 sh	$529.17	−$366K	190,330
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−480 sh	$539.23	−$259K	187,804
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−332 sh	$534.16	−$177K	189,472
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−766 sh	$516.84	−$396K	205,003
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−473 sh	$536.02	−$254K	188,851
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−681 sh	$521.03	−$355K	199,663
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.5K sh	—	—	280
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−600 sh	$540.36	−$324K	187,204
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−280 sh	$551.24	−$154K	187,164
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,450 sh	$517.86	−$1.27M	202,553
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+24.5K sh	$15.80	+$387K	211,684
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,432 sh	$525.05	−$1.28M	194,222
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−40 sh	$545.79	−$21.8K	187,164
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,066 sh	$526.00	−$561K	193,156
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,996 sh	$515.81	−$1.03M	205,769
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−280 sh	—	—	0
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+280 sh	$15.80	+$4,424	187,444
2026-01-09	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,199 sh	$524.10	−$628K	196,654
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.8K sh	—	—	24,800
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,316 sh	$550.93	−$2.38M	206,080
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−624 sh	$547.75	−$342K	211,340
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−535 sh	$548.51	−$293K	210,805
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−409 sh	$549.99	−$225K	210,396
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−160 sh	$555.39	−$88.9K	187,164
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−7,193 sh	$551.67	−$3.97M	198,887
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,001 sh	$553.83	−$2.77M	188,353
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,533 sh	$552.74	−$3.06M	193,354
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,029 sh	$555.00	−$571K	187,324
2025-12-10	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+24.8K sh	$15.80	+$392K	211,964
2025-08-13	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,152 sh	$366.22	−$1.15M	296,947
2025-08-13	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,716 sh	$365.19	−$627K	300,099
2025-08-13	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−7,119 sh	$367.31	−$2.61M	289,828
2025-08-13	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−22.7K sh	$371.53	−$8.44M	244,461
2025-08-13	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−24.2K sh	$373.35	−$9.02M	191,319

Recent filings

Accepted (ET)
Jun 104
FRIEDMAN PAUL A0001236927-26-000003
SEC(opens sec.gov)
Jan 134
FRIEDMAN PAUL A0001628280-26-001976
SEC(opens sec.gov)
Jan 134
FRIEDMAN PAUL A0001628280-26-001981
SEC(opens sec.gov)

Companies

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805